UY30047A1 - Moduladores de estrogenos - Google Patents

Moduladores de estrogenos

Info

Publication number
UY30047A1
UY30047A1 UY30047A UY30047A UY30047A1 UY 30047 A1 UY30047 A1 UY 30047A1 UY 30047 A UY30047 A UY 30047A UY 30047 A UY30047 A UY 30047A UY 30047 A1 UY30047 A1 UY 30047A1
Authority
UY
Uruguay
Prior art keywords
modulators
strogen
isoxazoles
present application
new class
Prior art date
Application number
UY30047A
Other languages
English (en)
Inventor
Veerabahu Shanmugasundaram
Raj Kumar Raheja
Lorna Helen Mitchell
Sandra Marie Jennings
Stephen Douglas Barrett
Stephen Alan Fakhoury
Larry Don Bratton
Simon Bailey
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of UY30047A1 publication Critical patent/UY30047A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente solicitud se refiere a una nueva clase de isoxazoles y a su uso como moduladores de estrógenos.
UY30047A 2005-12-22 2006-12-20 Moduladores de estrogenos UY30047A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75278005P 2005-12-22 2005-12-22
US80523306P 2006-06-20 2006-06-20

Publications (1)

Publication Number Publication Date
UY30047A1 true UY30047A1 (es) 2007-07-31

Family

ID=38066616

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30047A UY30047A1 (es) 2005-12-22 2006-12-20 Moduladores de estrogenos

Country Status (17)

Country Link
US (2) US7470715B2 (es)
EP (1) EP1966170A2 (es)
JP (1) JP2009520808A (es)
KR (1) KR20080073346A (es)
AP (1) AP2008004481A0 (es)
AR (1) AR058611A1 (es)
AU (1) AU2006327877A1 (es)
BR (1) BRPI0620215A2 (es)
CA (1) CA2628596A1 (es)
EA (1) EA200801407A1 (es)
EC (1) ECSP088533A (es)
NL (1) NL2000351C2 (es)
NO (1) NO20082992L (es)
PE (1) PE20070815A1 (es)
RS (1) RS20080267A (es)
UY (1) UY30047A1 (es)
WO (1) WO2007072164A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2603490A4 (en) * 2010-08-10 2014-01-01 Abbvie Inc NEW TRPV3 MODULATORS
CN111938907B (zh) * 2020-08-12 2022-07-01 中国人民解放军陆军军医大学第一附属医院 一种鼻部手术后外敷面罩

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US171412A (en) * 1875-12-21 Improvement in buck-boards
US9799A (en) * 1853-06-21 Simon ikgeksoll
US207927A (en) * 1878-09-10 Improvement in horse hay-rakes
US525666A (en) * 1894-09-04 Axel sarnmark
US256210A (en) * 1882-04-11 Bodolphe t
GB1012182A (en) 1963-04-23 1965-12-08 Ass Portland Cement Improvement in the manufacture of hydraulic cement
JPS63108339A (ja) 1986-10-27 1988-05-13 Fuji Photo Film Co Ltd ハロゲン化銀カラ−感光材料の処理方法
GB2201672A (en) 1986-12-18 1988-09-07 Shell Int Research Diphenyl ether compounds
US4933464A (en) * 1988-04-25 1990-06-12 W. R. Grace & Co.-Conn. Process for forming 3-phenylisoxazolines and 3-phenylisoxazoles
US4952700A (en) 1988-04-25 1990-08-28 W.R. Grace & Co.-Conn. Preparation of isoxazolines and isoxazoles
JPH089600B2 (ja) 1988-08-02 1996-01-31 三井東圧化学株式会社 ピラゾールカルボン酸類の製造方法
JPH089599B2 (ja) 1988-08-02 1996-01-31 三井東圧化学株式会社 ピラゾールカルボン酸類の製造方法
IT1228288B (it) 1989-01-09 1991-06-07 Zambon Spa Composti ad attivita' antiserotoninica
DE4016049A1 (de) * 1990-05-18 1991-11-21 Basf Ag 3-isoxazolylbenzylester, ihre herstellung und ihre verwendung
US5256632A (en) * 1990-05-30 1993-10-26 Bayer Aktiengesellschaft Herbicidal sulphonylated carboxamides
DK178590D0 (da) 1990-07-26 1990-07-26 Novo Nordisk As 1,4-disubstituerede piperaziner
US5260322A (en) 1990-10-08 1993-11-09 Merck & Co., Inc. Angiotension II antagonists in the treatment of hyperuricemia
JP3010387B2 (ja) 1991-05-13 2000-02-21 コニカ株式会社 ピラゾール誘導体
JP3454531B2 (ja) * 1991-11-07 2003-10-06 三共株式会社 ニトロキシアルキルアミド誘導体
DE4137940A1 (de) 1991-11-18 1993-05-19 Basf Ag 3-isoxazolylphenylverbindungen, ihre herstellung und ihre verwendung
AU5891494A (en) 1993-01-29 1994-08-15 Nippon Soda Co., Ltd. Heterocyclic derivative
IT1263751B (it) 1993-02-05 1996-08-27 Mini Ricerca Scient Tecnolog Derivati di esteri arilacetici ad attivita' fungicida
JPH06236057A (ja) 1993-02-10 1994-08-23 Fuji Xerox Co Ltd 電子写真感光体
JPH07304748A (ja) 1993-06-29 1995-11-21 Nissan Chem Ind Ltd アルドキシム誘導体および農園芸用殺菌剤
WO1995011896A1 (fr) 1993-10-26 1995-05-04 Nissan Chemical Industries, Ltd. Derive de pyrazole substitue, et fongicide agricole et horticole
JP3791015B2 (ja) 1994-03-31 2006-06-28 日産化学工業株式会社 スルホンアミド誘導体の製造方法
JP3329061B2 (ja) 1994-04-19 2002-09-30 三菱化学株式会社 電子写真用感光体
JPH0873436A (ja) 1994-07-06 1996-03-19 Nissan Chem Ind Ltd セミカルバゾン誘導体
US5486534A (en) 1994-07-21 1996-01-23 G. D. Searle & Co. 3,4-substituted pyrazoles for the treatment of inflammation
FR2725988B1 (fr) 1994-10-24 1997-01-24 Roussel Uclaf Nouveaux derives de pyrazolones et pyrazoles acides, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
CN1117080A (zh) 1995-01-11 1996-02-21 刘波 苏云金芽胞杆菌培养基
CN1107058C (zh) * 1995-02-13 2003-04-30 G·D·瑟尔公司 用于治疗类症的取代的异噁唑
WO1996033994A1 (fr) 1995-04-28 1996-10-31 Nippon Soda Co., Ltd. Derives amino-substitues, leur procede de preparation et herbicide
EP0833622B8 (en) * 1995-06-12 2005-10-12 G.D. Searle & Co. Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
KR19990064310A (ko) 1995-10-17 1999-07-26 윌리암스 로저 에이 시클로옥시게나제-2의 검출방법
EP0880363B1 (en) 1996-02-13 2002-09-11 G.D. SEARLE & CO. Combinations, having immunosuppressive effects, containing a cyclooxygenase-2 inhibitor and a leukotriene a 4 hydrolase inhibitor
PL195955B1 (pl) 1996-04-12 2007-11-30 Searle & Co Związek, pochodna benzenosulfonamidu, sposób jegowytwarzania, kompozycja farmaceutyczna zawierająca go oraz jego zastosowanie
JP3399756B2 (ja) * 1996-10-22 2003-04-21 三菱製紙株式会社 平版印刷版の処理方法
DE59807486D1 (de) * 1997-09-05 2003-04-17 Basf Ag Verfahren zur herstellung (hetero)aromatischer hydroxylamine
US5972986A (en) * 1997-10-14 1999-10-26 G.D. Searle & Co. Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
CA2372912C (en) 1997-10-14 2008-12-02 G.D. Searle & Co. Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
JPH11124306A (ja) 1997-10-22 1999-05-11 Nissan Chem Ind Ltd 殺虫・殺ダニ・殺菌剤組成物
US6262098B1 (en) * 1998-08-07 2001-07-17 Chiron Corporation Estrogen receptor modulators
AU1199600A (en) 1998-10-02 2000-04-26 Board Of Trustees Of The University Of Illinois, The Estrogen receptor ligands
US6436923B1 (en) * 1999-03-17 2002-08-20 Signal Pharmaceuticals, Inc. Compounds and methods for modulation of estrogen receptors
AU3253800A (en) 1999-05-14 2000-11-16 Pfizer Products Inc. Combination therapy for the treatment of migraine
US6413965B1 (en) 1999-06-30 2002-07-02 Pfizer Inc. Compositions and treatment for diabetic complications
CO5190678A1 (es) 1999-06-30 2002-08-29 Pfizer Prod Inc Terapia combinada para el tratamiento de la migrana
JP4645871B2 (ja) 1999-09-24 2011-03-09 日本農薬株式会社 イソキサゾリン誘導体及び除草剤並びにその使用方法
CA2390113A1 (en) 1999-12-02 2001-06-07 Maurizio Schwarzenbach Aminoheterocyclylamides as pesticides and antiparasitic agents
JP2003531202A (ja) 2000-04-25 2003-10-21 ファルマシア・コーポレーション ３，４−ジ（カルボシクリルまたはヘテロシクリル）チオフェンの位置選択的合成
JP2001302662A (ja) 2000-04-27 2001-10-31 Nissan Chem Ind Ltd アクリロニトリル化合物
EP1339683B1 (en) 2000-11-27 2006-06-14 Merck & Co., Inc. Estrogen receptor modulators
US6693295B2 (en) * 2000-12-25 2004-02-17 Fuji Photo Film Co., Ltd. Indole derivative, material for light-emitting device and light-emitting device using the same
WO2002079163A1 (en) 2001-03-30 2002-10-10 Smithkline Beecham Corporation Aminopyridine derivatives as estrogen receptor modulators
US6673818B2 (en) 2001-04-20 2004-01-06 Pharmacia Corporation Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
EP1270535A3 (de) * 2001-06-20 2004-02-18 Clariant GmbH Verfahren zur Herstellung von substituierten aromatischen Verbindungen
US6960607B2 (en) 2001-12-13 2005-11-01 Wyeth Naphthyl benzoxazoles and benzisoxazoles as estrogenic agents
US6884814B2 (en) 2001-12-13 2005-04-26 Wyeth Phenyl benzisoxazoles as estrogenic agents
GB0130339D0 (en) 2001-12-19 2002-02-06 Lilly Co Eli Isochroman compounds
AU2002356301A1 (en) 2001-12-21 2003-07-15 Cancer Research Technology Ltd. 3,4-diarylpyrazoles and their use in the therapy of cancer
AU2002367426A1 (en) 2001-12-28 2003-07-24 Takeda Chemical Industries, Ltd. Neurotrophic factor production/secretion accelerator
US6803379B2 (en) * 2002-06-04 2004-10-12 Jose A. Fernandez-Pol Pharmacological agents and methods of treatment that inactivate pathogenic prokaryotic and eukaryotic cells and viruses by attacking highly conserved domains in structural metalloprotein and metalloenzyme targets
DK1606307T3 (da) 2002-07-03 2008-01-21 Ortho Mcneil Pharm Inc Östrieno(3,2-b)/(3,4-b)pyrrolderivater egnede som modulatorer for östrogenreceptorer
JP2006508927A (ja) 2002-09-19 2006-03-16 メルク　エンド　カムパニー　インコーポレーテッド エストロゲン受容体修飾因子
CA2512000C (en) 2002-12-26 2011-08-09 Eisai Co., Ltd. Selective estrogen receptor modulator
WO2004073612A2 (en) 2003-02-13 2004-09-02 Merck & Co. Inc. Estrogen receptor modulators
WO2004073610A2 (en) 2003-02-13 2004-09-02 Merck & Co., Inc. Estrogen receptor modulators
AU2004251176A1 (en) 2003-05-31 2005-01-06 Janssen Pharmaceutica, N.V. Cyclohexyl derivatives as selective estrogen receptor modulators
DE602004014806D1 (de) 2003-10-08 2008-08-14 Smithkline Beecham Corp Triphenylethyleneverbindungen als selektive modulatoren des östrogenrezeptors
EP1747182A2 (en) 2004-05-04 2007-01-31 Acadia Pharmaceuticals Inc. Compounds with activity at estrogen receptor

Also Published As

Publication number Publication date
NL2000351A1 (nl) 2007-06-25
CA2628596A1 (en) 2007-06-28
BRPI0620215A2 (pt) 2011-11-01
NL2000351C2 (nl) 2007-09-11
AR058611A1 (es) 2008-02-13
AU2006327877A1 (en) 2007-06-28
US20070149564A1 (en) 2007-06-28
NO20082992L (no) 2008-09-22
WO2007072164A3 (en) 2007-10-04
US7470715B2 (en) 2008-12-30
ECSP088533A (es) 2008-07-30
JP2009520808A (ja) 2009-05-28
US20090131397A1 (en) 2009-05-21
PE20070815A1 (es) 2007-08-27
RS20080267A (en) 2009-05-06
KR20080073346A (ko) 2008-08-08
WO2007072164A2 (en) 2007-06-28
EA200801407A1 (ru) 2008-10-30
EP1966170A2 (en) 2008-09-10
AP2008004481A0 (en) 2008-06-30

Similar Documents

Publication Publication Date Title
AR067815A1 (es) Composicion de recubrimiento electrodepositable que contiene una guanidina ciclica
CR11523A (es) Agentes fijadores y epitopos wise
CO6491082A2 (es) Derivados de n 1-sulfonil-5-fluoropirimidinona
HN2006016313A (es) Derivados de amida sustituida y metodos de uso
DOP2006000290A (es) Moduladores de estrógenos
AR072901A1 (es) Uso de 5- fluorcitosina como fungicida
CR11267A (es) Preparacion solida que contiene alogliptina y clorhidrato de metformina
CR20110453A (es) Combinación de un inhibidor de nucléosido polimerasa con un inhibidor de proteasa macrocíclica y su uso en el tratamiento de hepatitis c, fibrosis hepática y función hepática alterada
CR10372A (es) Anticuerpos anti-tat226 e inmunoconjugados
ECSP066761A (es) Moduladores de receptores de androgenos
UY33754A (es) Monobactamas
CL2008002041A1 (es) Compuestos derivados de piperidina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar ansiedad.
CO6341476A2 (es) Derivados de piridino-piridinonas, su preparacion y su aplicacion en terapeutica
CL2009001804A1 (es) Uso de un copolimero de vinilamina-vinilformamida y un portador para preparar una composicion destinada a fortalecer las fibras queratinosas.
UY31152A1 (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica
CR20110034A (es) Peptidos de señalizacion de la crkl
BRPI0815373A2 (pt) Derivados de ciclo-hexeno e o uso dos mesmos como fragrâncias
GT200500263A (es) Enzima lacasa novedosa y su uso
ES2422173T3 (es) Composiciones que contienen aecuorina y procedimientos de uso de las mismas
CL2009000665A1 (es) Compuestos derivados de pirrolidinilo; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la ansiedad, depresion o ambas.
UY29594A1 (es) Derivados de benzotiazol-2-ona como inhibidores de lipasas y fosfolipasas
UY31139A1 (es) Formas cristalinas de 3-(2r-tetrahidrofuril-metil)-2-tioxantina
BRPI0907043A2 (pt) Composição, uso do composto, e, composto
ECSP088533A (es) Moduladores de estrógeno
CR10093A (es) Modulares de estrógenos

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160928